2012•Journal of Apoplexy and Nervous DiseasesRequires access

Expression changes and significance of SV2A in the hippocampus of rats with amygdala-kindling epilepsy models

Lan Chu

Open publisher page 0 citations

Abstract

Objective To establish the amygdala-kindling epilepsy rats models,and measure the expression of SV2A to explore the pathogenesis of epilepsy.Methods To establish model of chronic epilepsy by stimulating the amygdala as the epilepsy group,and to perfuse antiepileptic drug of levetiracetam into stomach as the treatment group.The dynamic changes of SV2A were examined by Real-time PCR and immunohistochemistry in the hippocamp tissue.Results Compared with the sham control group,epilepsy group showed decreased the expression after one week,and SV2A in epilepsy eight weeks was higher than control group(P0.05).However,there was significant difference between group after two weeks,four weeks and eight weeks before and after treatment(P0.05).Conclusion The expression of SV2A was closely related to epileptic seizures.

About this research paper

What this paper is about

Objective To establish the amygdala-kindling epilepsy rats models,and measure the expression of SV2A to explore the pathogenesis of epilepsy.Methods To establish model of chronic epilepsy by stimulating the amygdala as the epilepsy group,and to perfuse antiepileptic drug of levetiracetam into stomach as the treatment group.The dynamic changes of SV2A were examined by Real-time PCR and immunohistochemistry in the hippocamp tissue.Results Compared with the sham control group,epilepsy group showed decreased the expression after one week,and SV2A in epilepsy eight weeks was higher than control group(P0.05).However,there was significant difference between group after two weeks,four weeks and eight weeks before and after treatment(P0.05).Conclusion The expression of SV2A was closely related to epileptic seizures.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To establish the amygdala-kindling epilepsy rats models,and measure the expression of SV2A to explore the pathogenesis of epilepsy.Methods To establish model of chronic epilepsy by stimulating the amygdala as the epilepsy group,and to perfuse antiepileptic drug of levetiracetam into stomach as the treatment group.The dynamic changes of SV2A were examined by Real-time PCR and immunohistochemistry in the hippocamp tissue.Results Compared with the sham control group,epilepsy group showed decreased the expression after one week,and SV2A in epilepsy eight weeks was higher than control group(P0.05).However,there was significant difference between group after two weeks,four weeks and eight weeks before and after treatment(P0.05).Conclusion The expression of SV2A was closely related to epileptic seizures.

Key concepts: Epilepsy, Kindling, Hippocampus, Amygdala, Levetiracetam, Kindling model, Medicine, Immunohistochemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression changes and significance of SV2A in the hippocampus of rats with amygdala-kindling epilepsy models — Research Paper | ScholarLens